COP2 Stock Overview
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
CompuGroup Medical SE & Co. KGaA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €28.72 |
| 52 Week High | €51.80 |
| 52 Week Low | €26.78 |
| Beta | 1.0 |
| 1 Month Change | -4.27% |
| 3 Month Change | -27.58% |
| 1 Year Change | -40.56% |
| 3 Year Change | -55.33% |
| 5 Year Change | -51.16% |
| Change since IPO | -41.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| COP2 | AT Healthcare Services | AT Market | |
|---|---|---|---|
| 7D | 0.3% | 0.4% | 1.0% |
| 1Y | -40.6% | -0.4% | 4.6% |
Return vs Industry: COP2 underperformed the Austrian Healthcare Services industry which returned -0.4% over the past year.
Return vs Market: COP2 underperformed the Austrian Market which returned 4.6% over the past year.
Price Volatility
| COP2 volatility | |
|---|---|
| COP2 Average Weekly Movement | 7.1% |
| Healthcare Services Industry Average Movement | 6.6% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in AT Market | 5.1% |
| 10% least volatile stocks in AT Market | 1.7% |
Stable Share Price: COP2's share price has been volatile over the past 3 months.
Volatility Over Time: COP2's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 9,199 | Michael Rauch | www.cgm.com |
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. The company’s Ambulatory Information Systems segment develop and sell practice management software for registered physicians, medical care centers, and physician networks; and offers supplementary internet and intranet solutions. Its Pharmacy Information Systems segment develop and sell administrative and billing related software applications, which includes procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies.
CompuGroup Medical SE & Co. KGaA Fundamentals Summary
| COP2 fundamental statistics | |
|---|---|
| Market cap | €1.49b |
| Earnings (TTM) | €45.92m |
| Revenue (TTM) | €1.23b |
32.6x
P/E Ratio1.2x
P/S RatioIs COP2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COP2 income statement (TTM) | |
|---|---|
| Revenue | €1.23b |
| Cost of Revenue | €813.16m |
| Gross Profit | €414.75m |
| Other Expenses | €368.84m |
| Earnings | €45.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 33.78% |
| Net Profit Margin | 3.74% |
| Debt/Equity Ratio | 106.2% |
How did COP2 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield114%
Payout RatioDoes COP2 pay a reliable dividends?
See COP2 dividend history and benchmarks| CompuGroup Medical SE KGaA dividend dates | |
|---|---|
| Ex Dividend Date | May 23 2024 |
| Dividend Pay Date | May 27 2024 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 21 days |
Does COP2 pay a reliable dividends?
See COP2 dividend history and benchmarks